Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine aminotransferase pseudogene is a **non-functional segment of DNA that resembles the gene encoding the enzyme tyrosine aminotransferase (TAT)**. Pseudogenes are typically generated by duplication or retrotransposition events but lack the regulatory features or sequence integrity to produce functional protein products[1][3]. The pseudogene ENSG00000233583 does not code for an active enzyme and is not implicated in normal physiology or disease, in contrast to the functional TAT gene, which is important in tyrosine metabolism[4][6]. Pseudogenes can occasionally be transcribed at low levels but are generally not of therapeutic or diagnostic interest[1].\n\nSummary of why this is not a therapeutic target: \nThis entry is a **pseudogene**, not a protein-coding gene. It does not yield a functional receptor, enzyme, or other molecule suitable as a drug target. It is often included in gene annotation databases for completeness, but not as a target for intervention or drug development[1][3]. This should not be confused with the functional TAT gene (ENSG00000198650), which encodes the active tyrosine aminotransferase enzyme relevant for metabolism and disease[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine aminotransferase pseudogene.